TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Vistin Pharma AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
36,217
|
38,734
|
27,329 |
| Financial expenses |
1,332
|
3,023
|
1,071 |
| Earnings before taxes |
7,173
|
5,546
|
-345 |
| Total assets |
31,739
|
35,157
|
38,429 |
| Current assets |
11,331
|
14,471
|
14,986 |
| Current liabilities |
16,466
|
19,736
|
26,516 |
| Equity capital |
14,716
|
9,470
|
5,147 |
| - share capital |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.4%
|
26.9%
|
13.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
19.8%
|
14.3%
|
-1.3% |
| Return on assets (ROA) |
26.8%
|
24.4%
|
1.9% |
| Current ratio |
68.8%
|
73.3%
|
56.5% |
| Return on equity (ROE) |
48.7%
|
58.6%
|
-6.7% |
| Change turnover |
-537
|
13,141
|
1,127 |
| Change turnover % |
-1%
|
51%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.